Keyphrases
Leucine-rich Repeat Kinase 2 (LRRK2)
100%
Parkinson's Disease
41%
Phosphorylation
38%
Rab10
32%
Pathway Activity
19%
Leucine-rich Repeat Protein
16%
Protein Kinase 2
16%
Membrane Recruitment
16%
Kinase Cascade
16%
Membrane Activation
16%
Kinase Activity
16%
Rab29
15%
Rab Proteins
11%
LRRK2 Inhibitors
11%
Rab8a
11%
Parkinson
11%
Peripheral Blood Neutrophils
9%
Human Neutrophils
9%
Human Peripheral Blood
8%
Orally Bioavailable
8%
Protein Antibody
8%
In Vivo Activity
8%
Azaindazole
8%
Neutrophil Isolation
8%
RILPL2
8%
Penetrant
8%
WD40 Domain
8%
Microtubule Binding
8%
Multiplexing
8%
2-parts
8%
Mitophagy
8%
Degrader
8%
Targeted Mass Spectrometry
8%
Blood-brain Barrier
8%
Proteolysis Targeting chimera (PROTAC)
8%
Rab GTPase
5%
Kinase Inhibitor
5%
Biochemistry, Genetics and Molecular Biology
Leucine-Rich Repeat
91%
Kinase
85%
Phosphotransferase
85%
LRRK2
25%
Protein Kinases
17%
Neutrophil Granulocyte
11%
Crystal Structure
10%
Mass Spectrometry
8%
WD40 Repeat
8%
Drive
8%
Blood Brain Barrier
8%
Protein Catabolism
8%
Mitophagy
8%
Pharmacology, Toxicology and Pharmaceutical Science
Phosphotransferase
43%
Leucine Rich Repeat Kinase 2
36%
Parkinson's Disease
34%
Rab Protein
13%
Protein Kinases
11%
Biological Marker
9%
Nigericin
8%
Protein Antibody
8%
Leucine
8%
Disease
6%
Brain Extract
5%
Monensin
5%
Rebastinib
5%